R
ResMed Inc.
RMD · NYSE · USD
Historical Earnings
| Quarter | Reported | EPS est | EPS act | Surprise | Rev est | Rev act | Surprise | Reaction |
|---|---|---|---|---|---|---|---|---|
| Q4 2026 | Aug 6, 2026 | 2.89 | 2.95 | +2.1% | $1.5B | $1.5B | +0.2% | −5.06% |
| Q3 2026 | Apr 30, 2026 | 2.80 | 2.86 | +2.1% | $1.4B | $1.4B | +0.8% | −4.11% |
| Q2 2026 | Jan 29, 2026 | 2.74 | 2.81 | +2.6% | $1.4B | $1.4B | +1.6% | +0.27% |
| Q1 2026 | Oct 30, 2025 | 2.51 | 2.55 | +1.6% | $1.3B | $1.3B | +0.2% | −2.13% |
| Q4 2025 | Jul 31, 2025 | 2.46 | 2.55 | +3.7% | $1.3B | $1.3B | +1.3% | +2.67% |
| Q3 2025 | Apr 23, 2025 | 2.38 | 2.37 | −0.4% | $1.3B | $1.3B | +0.3% | +10.10% |
| Q2 2025 | Jan 30, 2025 | 2.32 | 2.43 | +4.7% | $1.3B | $1.3B | +1.2% | −8.33% |
| Q1 2025 | Oct 24, 2024 | 2.04 | 2.20 | +7.8% | $1.2B | $1.2B | +3.3% | +7.12% |
Detailed View
Q1 2027Oct 29, 2026Q4 2026Aug 6, 2026−5.06%Q3 2026Apr 30, 2026−4.11%Q2 2026Jan 29, 2026+0.27%Q1 2026Oct 30, 2025−2.13%Q4 2025Jul 31, 2025+2.67%Q3 2025Apr 23, 2025+10.10%Q2 2025Jan 30, 2025−8.33%Q1 2025Oct 24, 2024+7.12%Q4 2024Aug 1, 2024Q3 2024Apr 25, 2024Q2 2024Jan 24, 2024
2026 Q4 Metrics
| Metric | Estimate | Actual | Surprise | Y/Y |
|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | Beat +0.16% | +8.6% |
| EPS | 2.89 | 2.95 | Beat +2.08% | +15.7% |
| Diluted EPS (GAAP) | — | 2.64 | — | +2.3% |
Documents
- Earnings call transcript — Q4 2026Transcript · Aug 6, 2026 · 75 speaker turns
- 8-K — Q4 20268-K · Sep 1, 2026 · sec.gov
- 8-K — Q4 20268-K · Aug 17, 2026 · sec.gov
- 10-K — Q4 202610-K · Aug 13, 2026 · sec.gov
- 8-K — Q4 20268-K · Aug 6, 2026 · sec.gov